RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 Long-Term Ranibizumab Effective in Diabetic Macular Edema
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 17
SP 13
OP 13
DO 10.1177/155989771317009
UL http://mdc.sagepub.com/content/13/17/13.1.abstract
AB In patients with diabetic macular edema, long-term intravitreal injections of ranibizumab maintains best-corrected visual acuity and central retinal subfield thickness improvements over 36 months, with no new or increased safety concerns. This article discusses the final analysis of the 36-month study comprising: A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-Label Extension Study [RESTORE; NCT00687804].